Neil E Kay Selected Research

Neil E Kay Research Topics

Disease

94	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 10/2002
28	Neoplasms (Cancer) 01/2022 - 01/2004
20	Disease Progression 10/2022 - 01/2002
8	Lymphoma (Lymphomas) 01/2022 - 08/2004
8	Leukemia 06/2015 - 12/2003
7	Lymphocytosis 01/2022 - 01/2013
6	Multiple Myeloma 01/2022 - 02/2002
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 04/2007
5	Residual Neoplasm 01/2022 - 01/2007
5	Chromosome Aberrations (Chromosome Abnormalities) 07/2014 - 09/2006
4	Infections 07/2014 - 01/2004
3	Atrial Fibrillation 01/2021 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 04/2006
3	Fatigue 12/2018 - 10/2013
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 10/2011
2	Cytokine Release Syndrome 01/2021 - 01/2019
2	Tumor Lysis Syndrome 10/2020 - 12/2018
2	Diarrhea 12/2018 - 07/2014
2	Cytopenia 11/2018 - 04/2010
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2018 - 02/2006
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015 - 07/2010
2	Lymphoid Leukemia 07/2014 - 12/2003
2	Autoimmune Diseases (Autoimmune Disease) 01/2011 - 06/2009
2	Hypoxia (Hypoxemia) 03/2010 - 04/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2006 - 12/2003
1	Human Influenza (Influenza) 12/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Trisomy (Trisomies) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Hypertension (High Blood Pressure) 12/2018
1	Hemorrhage 12/2018
1	Weight Loss (Weight Reduction) 12/2018
1	Chronic Disease (Chronic Diseases) 12/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2018
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2018
1	Purpura 10/2018

Drug/Important Bio-Agent (IBA)

18	ibrutinibIBA 10/2022 - 07/2014
16	Rituximab (Mabthera)FDA Link 01/2019 - 01/2007
9	Biological ProductsIBA 01/2022 - 01/2002
9	Pentostatin (Nipent)FDA LinkGeneric 01/2019 - 01/2004
9	Proteins (Proteins, Gene)FDA Link 06/2015 - 05/2002
8	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 08/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2007
7	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 05/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 08/2004
5	Pharmaceutical PreparationsIBA 09/2015 - 07/2007
4	venetoclaxIBA 10/2022 - 01/2020
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
4	Alemtuzumab (Campath)FDA Link 01/2019 - 10/2008
4	ofatumumab FDA Link 12/2018 - 03/2011
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 03/2013
3	AntigensIBA 01/2022 - 01/2008
3	B-Cell Maturation AntigenIBA 01/2022 - 01/2021
3	VaccinesIBA 01/2022 - 07/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2006
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 01/2004
3	MicroRNAs (MicroRNA)IBA 06/2015 - 01/2011
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2015
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2010
2	fludarabineIBA 01/2019 - 01/2009
2	serum P-component (CIt)IBA 01/2019 - 11/2013
2	Bendamustine Hydrochloride FDA Link 08/2017 - 01/2015
2	Monoclonal AntibodiesIBA 11/2016 - 02/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2015 - 02/2011
2	idelalisibIBA 05/2015 - 01/2013
2	polyphenon EIBA 01/2013 - 08/2009
2	TeaIBA 01/2013 - 08/2004
2	IntegrinsIBA 01/2013 - 10/2011
2	Protein Kinases (Protein Kinase)IBA 01/2011 - 09/2006
2	purineIBA 04/2010 - 04/2006
2	Complement System Proteins (Complement)IBA 06/2009 - 12/2008
2	Chlorambucil (Leukeran)FDA Link 01/2009 - 01/2004
2	NF-kappa B (NF-kB)IBA 11/2008 - 07/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2008 - 08/2004
2	B-Cell Activating FactorIBA 02/2006 - 10/2002
1	Herpes Zoster VaccineIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021
1	CateninsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Exportin 1 ProteinIBA 01/2021
1	ChemokinesIBA 01/2021
1	Biological FactorsIBA 12/2020
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	Axl Receptor Tyrosine KinaseIBA 12/2018
1	Inosine Triphosphate (ITP)IBA 10/2018

Therapy/Procedure

40	Therapeutics 01/2022 - 01/2004
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 02/2009 - 04/2006
2	Aftercare (After-Treatment) 01/2019 - 01/2009
1	Duration of Therapy 10/2018